Quercetin downregulates Mcl-1 by acting on mRNA stability and protein degradation
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Quercetin downregulates Mcl-1 by acting on mRNA stability and protein degradation
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 105, Issue 2, Pages 221-230
Publisher
Springer Nature
Online
2011-07-13
DOI
10.1038/bjc.2011.229
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Flavonoids as Protein Kinase Inhibitors for Cancer Chemoprevention: Direct Binding and Molecular Modeling
- (2010) De-Xing Hou et al. ANTIOXIDANTS & REDOX SIGNALING
- Strategy to induce apoptosis and circumvent resistance in chronic lymphocytic leukaemia
- (2010) Rong Chen et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Signalling to drug resistance in CLL
- (2010) Erin Hertlein et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistance
- (2010) K. J. Campbell et al. BLOOD
- Quercetin induced apoptosis in association with death receptors and fludarabine in cells isolated from chronic lymphocytic leukaemia patients
- (2010) M Russo et al. BRITISH JOURNAL OF CANCER
- Cytoplasmic accumulation of the RNA binding protein HuR is central to tamoxifen resistance in estrogen receptor positive breast cancer cells
- (2010) Christine Hostetter et al. CANCER BIOLOGY & THERAPY
- Sorafenib Overcomes TRAIL Resistance of Hepatocellular Carcinoma Cells through the Inhibition of STAT3
- (2010) K.-F. Chen et al. CLINICAL CANCER RESEARCH
- Quercetin Induces Tumor-Selective Apoptosis through Downregulation of Mcl-1 and Activation of Bax
- (2010) S. Cheng et al. CLINICAL CANCER RESEARCH
- Mcl-1; the molecular regulation of protein function
- (2010) Luke W. Thomas et al. FEBS LETTERS
- Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
- (2010) M Hallek et al. LANCET
- Vinblastine Induces Acute, Cell Cycle Phase–Independent Apoptosis in Some Leukemias and Lymphomas and Can Induce Acute Apoptosis in Others when Mcl-1 Is Suppressed
- (2010) Bethany L. Salerni et al. MOLECULAR CANCER THERAPEUTICS
- Molecular basis of CLL
- (2010) Yuri Pekarsky et al. SEMINARS IN CANCER BIOLOGY
- Chemical inhibitors destabilize HuR binding to the AU-rich element of TNF-α mRNA
- (2009) Min-Ju Chae et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- p38 Mitogen-activated protein kinase stabilizes SMN mRNA through RNA binding protein HuR
- (2009) Faraz Farooq et al. HUMAN MOLECULAR GENETICS
- Activation of phosphatidylinositol 3-kinase is required for tumor necrosis factor-α-induced upregulation of matrix metalloproteinase-9: Its direct inhibition by quercetin
- (2009) Mun Kyung Hwang et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Inhibitory Effect of Flavonoids on 26S Proteasome Activity
- (2009) Tsui-Ling Chang JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Translation inhibition during cell cycle arrest and apoptosis: Mcl-1 is a novel target for RNA binding protein CUGBP2
- (2008) Dharmalingam Subramaniam et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Regulation of antiapoptotic MCL-1 function by gossypol: Mechanistic insights from in vitro reconstituted systems
- (2008) Aitor Etxebarria et al. BIOCHEMICAL PHARMACOLOGY
- Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells
- (2008) Simone Reuter et al. BIOCHEMICAL PHARMACOLOGY
- Mcl-1 expression predicts progression-free survival in chronic lymphocytic leukemia patients treated with pentostatin, cyclophosphamide, and rituximab
- (2008) F. T. Awan et al. BLOOD
- Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers
- (2008) C. Pepper et al. BLOOD
- Concurrent up-regulation of BCL-XL and BCL2A1 induces approximately 1000-fold resistance to ABT-737 in chronic lymphocytic leukemia
- (2008) M. Vogler et al. BLOOD
- Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia
- (2008) C. S. Tam et al. BLOOD
- Dietary flavonoids inhibit the anticancer effects of the proteasome inhibitor bortezomib
- (2008) F.-T. Liu et al. BLOOD
- AT-101 induces apoptosis in CLL B cells and overcomes stromal cell-mediated Mcl-1 induction and drug resistance
- (2008) K. Balakrishnan et al. BLOOD
- Raf and MEK Protein Kinases Are Direct Molecular Targets for the Chemopreventive Effect of Quercetin, a Major Flavonol in Red Wine
- (2008) K. W. Lee et al. CANCER RESEARCH
- Mcl-1 is a potential therapeutic target in multiple types of cancer
- (2008) C. Akgul CELLULAR AND MOLECULAR LIFE SCIENCES
- Chemoprevention of Cancer by Isothiocyanates and Anthocyanins: Mechanisms of Action and Structure-Activity Relationship
- (2008) C. Fimognari et al. CURRENT MEDICINAL CHEMISTRY
- NF-κB Activates Transcription of the RNA-Binding Factor HuR, via PI3K-AKT Signaling, to Promote Gastric Tumorigenesis
- (2008) Min–Ju Kang et al. GASTROENTEROLOGY
- Quercetin-induced ubiquitination and down-regulation of Her-2/neu
- (2008) Jae-Hoon Jeong et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Non-peptidic small molecule inhibitors against Bcl-2 for cancer therapy
- (2008) Asfar S. Azmi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa
- (2008) Y. Meng et al. MOLECULAR CANCER THERAPEUTICS
- Quercetin promotes degradation of survivin and thereby enhances death-receptor–mediated apoptosis in glioma cells
- (2008) Markus D. Siegelin et al. NEURO-ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started